Dose-related vestibular and cochlear effects of transtympanic gentamicin

American Journal of Otology

Volumn 19, Issue 2, 1998, Pages 170-179

  Wanamaker, Hayes H ^a,e   Lee Gruenwald, ^b   Damm, Karrie Jones ^c   Ogata, Yoichi ^d   Slepecky, Norma ^a  

^a Institute for Sensory Research   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d YAMAGUCHI UNIVERSITY   (Japan)

^e Central New York Ear Nose and Throat Consultants   (United States)

Author keywords

Aminoglycosides; Meniere's disease; Ototoxicity

Indexed keywords

GENTAMICIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; CONTROLLED STUDY; DOSE RESPONSE; GERBIL; HAIR CELL; MENIERE DISEASE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; VESTIBULE;

ANIMALS; ANTI-BACTERIAL AGENTS; COCHLEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; GENTAMICINS; GERBILLINAE; HAIR CELLS;

EID: 0031896632     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fowler E. Streptomycin treatment of vertigo. Trans Am Acad Ophtlmlmol Otolaryngol 1948;52:239-30I.
2. Hawkins JJ, Lurie M. The ototoxicity of streptomycin. Ann Otol 1952;61:789-806.
3. Hawkins J. Antibiotics and the inner ear. Trans Am Acad Opthalmol Otolaryngol 1959;63:205-218.
4. Schuknecht HE Ablation therapy in the management of Meniere's disease. Acta Otolaiyngol Suppl (Stockli) 1957:13:141.
5. Silverstein H. Streptomycin treatment for Meniere's disease. Ann Otol Rliinol Laryngol I984;93(suppl)l 12:44-7.
6. Silverstein H, Wanamaker H, Flanzer J, et al. Vestibular neurectomy in the United States-1990. Am J Otol 1992;13:23-30.
7. Lange GKHVE. Transtympanic treatment for Meniere's disease with gentamicin sulfate. In: Meniere's disease pathogenesis, diagnosis and treatment. Ed. Vosteen K-H, Schucknecht HF, Pfaltz CR. Stuttgart: Verlag, 1981 pp 208-11.
8. Beck C, Schmidt CL. 10 Years of experience with intratympanically applied streptomycin (gentamicin) in the therapy of Morbus Meniere. Arch Otorliinolaryngol 1978;221:149-52.
9. Morris C, Amadee R, Risey J, et al. Selective chemical vestibulectomy. Am J Otol 1990;6:395-400.
10. Shea JJ. Perfusion of the inner ear with streptomycin. Am J Otol 1989:102:150-5.
11. Monsell E, Shelton C, Anthony P, et al. Labyrinthotomy with streptomycin infusion: early results of a multicenter study. Am J Otol 1992;13:18-22.
12. Shea J, Ge X. Streptomycin perfusion of the labyrinth plus intravenous streptomycin. Otolaryngol Clin North Am 1994;27:317-24.
13. Nedzelski J, Chiong C, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: update of an ongoing study. Am J Otol 1993:14:278-82.
14. Nedzelski JM, Schessel DA, Bryce GE, et al. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992; 13:18-22.
15. Parnes L, Riddell D. Irritative spontaneous nystagmus following intratympanic gentamicin for Meniere's disease. Laryngoscope 1993;103:745-9.
16. Pyykko I, Ishizaki H, Kaasinen S, et al. Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 1994; 110:162-7.
17. Lundman L, Holmquist L, Bagger-Sjöbäck L, Juhn S. Round window membrane permeability. Acta Otolaryngol (Stockli) 1987;104: 472-80.
18. Hunter-Duvar IM. An electron microscopic study of the vestibular sensory epithelium. Acta Otolaryngology 1983;95:494-507.
19. Koegel LJ. Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, quinine, erythromycin and cis-platinum. Am J O/o/1985;6:190-9.
20. Matz G. Aminoglycoside cochlear toxicity. Otolaryngol Clin North Am 1993:26:705-12.
21. Berg K. The toxic effect of streptomycin on the vestibular and cochlear apparatus. An experimental study on cats. Acta Otolaryngol (Stockh) 1951 ;suppl- 97:5-17.
22. Lindemann H. Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol (Stockh) 1969;67:177-89.
23. Park J, Cohen G. Further observations of vestibular ototoxicity in the chick: effects of streptomycin on the ampullary sensory epithelium. Am J Otolaryngol 1984;5:387-93.
24. Kimura R, Iverson N, Sothard R. Selective lesions of the vestibular labyrinth. Ann Otol Rhinol Laryngol 1988;97:577-84.
25. Kimura R, Lee K, Nye C, et al. Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears. Acta Oto-Laryngologica 1991;1 11: 1021-30.
26. Lee S, Kimura R. Effect of ototoxic drug administration to the endolymphatic sac. Ann Otol Rhinol Laryngol 1991; 100:355-60.
27. McGee T, Olszewski J. Streptomycin sulfate and dihydrostreptomycin toxicity. Arch Otolaryngol 1962;75:295-3I1.
28. Pender D. Gentamicin tympanoclysis. Effects on the vestibular secretory cells. Am J Ololaryngol 1985;6:358-67.
29. Morris C, Aubert A, Shea J. Comparison of cochleotoxicity and vestibulotoxicity of streptomycin and gentamicin. In: Meniere's disease: perspectives in the '90s. Ed. Filipo R, Barbara M. New York: Kugler, 1994:485-90.
30. Hara M, Kimura R. Morphology of the membrana limitans. Ann Otol Rhinol Laryngol 1993;102:625-30.
31. Goycoolea MV. The round window membrane under normal and pathological conditions. Acta Otolaryngol (Stockh) 1992;suppl 493: 43-55.
32. Bagger-Sjöbäck D, Bergenius J, Lundberg A. Inner ear effects of topical gentamicin treatment in patients with Meniere's disease. AmJOtol 1990;11:406-10.
33. Jahnke K. Zur Feinstruckturen des Vestibularisapparats bei Meniere-Kranken. HNO 1987:35:43-50.
34. Wilson W, Schuknecht H. Update on the use of streptomycin therapy for Meniere's disease. Am J Otol 1980;2:108-11.
35. Warchol M, Lambert P, Goldstein B, et al. Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science 1993:259:1619-22.
36. Forge A, Lin L, Corwin J, et al. Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 1993;259: 1616-9.
37. Jones T, Nelson R. Recovery of vestibular function following hair cell destruction by streptomycin. Hear Res 1992;62:181-6.
38. Meza G, Solano-Flores L, Poblano A. Recovery of vestibular function in young guinea pigs after streptomycin treatment. Glutamate decarboxylase activity and nystagmus response assessment. Int J DevNeurosci 1992; 10:407.
39. Ogata Y, Slepecky N. Immunocytochemical localization of calmodulin in the vestibular end-organs of the gerbil. J Vestib Res 1997, in press.
40. Wersall J, Flock A. Suppression and restoration of the microphonic output from lateral line organ after local application of streptomycin. Life Sei 1964;3:1151-5.
41. Odkvist L, Magnusson M. Different strategies in the gentamicin treatment of Meniere's disease. In: Meniere 's disease: perspectives in the '90s. Ed. Filipo R, Barbara M. New York: Kugler, 1994.
42. Lundquist P, Wersall J. The ototoxic effects of gentamycine: an electromicroscopical study. Proceedings of Gentamycine, First International Symposium. Paris, 1967.
43. Lange G. Gentamicin and other ototoxic antibiotics for the transtympanic treatment for Meniere's disease. Arch Otorhinolaryngol 1989:246:269-70.
44. Singleton E, Schuknecht HF. Streptomycin sulfate in the management of Meniere's disease. Otolaryngol Clin North Am 1968;l:531-9.